Gastric Cytoprotectants

DBCAT005716Pharmacologic class

Medications used to combat ulcers by increasing mucosal protection, not by reducing gastric acid. A DrugBank category of 1 drug. 1 of them is approved.

Drugs: Sucralfate

What you can answer from here — as of July 21, 2022

1DrugEach linked to its full drug card

Listed above

4Drug targetsEvery drug–target pair in the class, with bond type

328Marketed productsAcross the regions we cover, with dosage forms and routes

4Routes of administrationHow the drugs in this class are given

Which targets do Gastric Cytoprotectants share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account